[Federal Register Volume 77, Number 37 (Friday, February 24, 2012)]
[Notices]
[Pages 11125-11126]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-4380]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60 Day-12-12ET]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-7570 
and send comments to Kimberly Lane, CDC Reports Clearance Officer, 1600 
Clifton Road, MS-D74, Atlanta, GA 30333 or send an email to 
[email protected].
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Communications Research to Inform Messages and Materials about 
Cytomegalovirus (CMV)--NEW--Prevention Research Branch, National Center 
on Birth Defects and Developmental Disabilities (NCBDDD), Centers for 
Disease Control and Prevention (CDC).

Background and Brief Description

    Cytomegalovirus (CMV) is the most common congenital infection in 
the U.S., causing disabilities in more than 5,500 children born each 
year (CDC, 2010). Disabilities related to congenital CMV are more 
common than other well-known childhood conditions, such as Down 
syndrome, fetal alcohol syndrome, and neural tube defects, and can 
include hearing or vision loss, mental retardation, psychomotor delays, 
and speech and language impairment.
    This is a multiphase communication research study that will help 
inform CDC's development materials and prevention messaging about 
congenital CMV. The information collection activities will consist of 
focus groups and an online survey. First, we plan to conduct 8 focus 
groups with 9 respondents each to identify potential messaging frames 
for communicating information about congenital CMV to the target 
audiences and adopting CMV preventive guidelines. We estimate that we 
will screen 144 women between the ages of 18-40 who are either pregnant 
or plan to get pregnant in the next 12 months, and who have a child 
under age 5, in order to recruit 72 participants for the focus groups. 
These focus groups will be conducted in Atlanta, Georgia (4) and San 
Diego, California (4). Findings from the focus groups will inform 
revisions to existing CDC messages and materials, which will be further 
tested in the second information collection activity, the online 
survey. Phase II research will include an online survey to test the 
revised messages and materials. This web survey will: (1) Examine 
baseline awareness and knowledge regarding CMV, (2) assess baseline CMV 
prevention behaviors prior to viewing CMV communication interventions 
(factsheet and video), (3) assess appeal and evaluate the impact of CMV 
communication interventions on their attitudes, beliefs, and behavioral 
intentions regarding prevention behaviors and (4) assess knowledge, 
attitudes and behaviors pre- and post- interventions with a larger 
target audience sample (N=500). We estimate that we will screen 3,000 
women in order to recruit 500 respondents for the online survey.
    All survey responses (100%) will be submitted through a secure 
survey Web site established for this project. No Information in 
Identifiable Form (IIF) collected will be transmitted to CDC. The only 
IIF being collected (respondent name, address, and phone number) is to 
be used by the focus group facilities to screen potential respondents 
to determine eligibility for the focus groups. The total estimated 
annual burden is 531 hours. There are no costs to the respondents other 
than their time.
    This request is submitted to obtain OMB clearance for one year.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total burden
      Type of respondent            Form name       respondents    responses per   response  (in       hours
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
                                              Phase I: Focus Groups
----------------------------------------------------------------------------------------------------------------
Women (age 18-40).............  Participant                  144               1            5/60              12
                                 Screener.
                                Demographic                   72               1           15/60              18
                                 questionnaire.
                                Informed consent              72               1           15/60              18
                                 form.

[[Page 11126]]

 
                                Focus group.....              72               1           90/60             108
----------------------------------------------------------------------------------------------------------------
                                              Phase II: Web Survey
----------------------------------------------------------------------------------------------------------------
Women (age 18-40).............  Participant                3,000               1            5/60             250
                                 screener.
                                Web Survey......             500               1           15/60             125
                               ---------------------------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............             531
----------------------------------------------------------------------------------------------------------------


Kimberly S. Lane,
Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. 2012-4380 Filed 2-23-12; 8:45 am]
BILLING CODE 4163-18-P